Abstract
The spontaneous autoimmune diabetes of the nonobese diabetic mouse and the BioBreeding diabetes-prone rat bears a striking similarity to human type 1 diabetes. For this reason it comes as a disappointment that interventions known to prevent the disease in the animal models proved ineffective in human trials. For an explanation I propose that, although the mechanism of b-cell destruction is the same in the three species, this common mechanism may be the end point of different loss-of-tolerance pathways in different human patients, only two of which are represented by the two animal models. Research strategies to address this problem will require more attention to immune subphenotypes or their corresponding subgenotypes in the human and, possibly, the generation of additional mouse models of spontaneous disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References and Recommended Reading
Pozzilli P: The DPT-1 trial: a negative result with lessons for future type 1 diabetes prevention. Diabetes Metab Res Rev 2002, 18:257–259.
Atkinson MA, Maclaren NK, Luchetta R: Insulitis and insulin dependent diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 1990, 39:933–937.
Gotfredsen CF, Buschard K, Grandsen EK: Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals. Diabetologia 1985, 28:933–935.
Lam-Tse WK, Lernmark A, Drexhage HA: Animal models of endocrine/organ-specific autoimmune diseases: do they really help us to understand human autoimmunity? Springer Semin Immunopathol 2002, 24:297–321.
Verge CF, Gianani R, Kawasaki E, et al.: Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996, 45:926–933.
Nerup J, Platz P, Andersen OO, et al.: HL-A antigens and diabetes mellitus. Lancet 1974, 2:864–866.
Gepts W: Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965, 14:619–633.
Foulis A.K, McGill M, Farquharson MA: Insulitis in type 1 (insulin-dependent) diabetes mellitus in man-macrophages, lymphocytes, and interferon-gamma containing cells. J Pathol 1991, 165:97–103.
MacMurray AJ, Moralejo DH, Kwitek AE, et al.: Lymphopenia in the BB rat model of type 1 diabetes is due to a mutation in a novel immune-associated nucleotide (Ian)-related gene. Genome Res 2002, 12:1029–1039. First discovery of a genetic mutation that explains a previously observed phenotype necessary for the development of diabetes.
Zipris D, Lazarus AH, Crow AR, et al.: Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. J Immunol 1991, 146:3763–3771.
Decallonne B, van Etten E, Giulietti A, et al.: Defect in activation-induced cell death in non-obese diabetic (NOD) T lymphocytes. J Autoimmun 2003, 20:219–226.
Rapoport MJ, Lazarus AH, Jaramillo A, et al.: Thymic T cell anergy in autoimmune nonobese diabetic mice is mediated by deficient T cell receptor regulation of the pathway of p21ras activation. J Exp Med 1993, 177:1221–1226.
Lamhamedi-Cherradi SE, Luan JJ, Eloy L, et al.: Resistance of T-cells to apoptosis in autoimmune diabetic (NOD) mice is increased early in life and is associated with dysregulated expression of Bcl-x. Diabetologia 1998, 41:178–184.
Colucci F, Bergman ML, Penha-Goncalves C, et al.: Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region. Proc Natl Acad Sci U S A 1997, 94:8670–8674.
Gombert JM, Herbelin A, Tancrede-Bohin E, et al.: Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse. Eur J Immunol 1996, 26:2989–2998.
Strid J, Lopes L, Marcinkiewicz J, et al.: A defect in bone marrow derived dendritic cell maturation in the nonobese diabetic mouse. Clin Exp Immunol 2001, 123:375–381.
Delovitch TL, Singh B: The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 1997, 7:727–738.
Marron MP, Raffel LJ, Garchon HJ, et al.: Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet 1997, 6:1275–1282.
Ueda H, Howson JM, Esposito L, et al.: Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003, 423:506–511. Demonstration of genetic variants on the same gene, associated with diabetes in both humans and mice.
Vafiadis P, Bennett ST, Todd JA, et al.: Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet. 1997, Mar; 15(3):289–92.
Anjos S, Nguyen A, Ounissi-Benkalha H, et al.: A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J Biol Chem 2002, 277:46478–46486.
Spatz M, Eibl N, Hink S, et al.: Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cells. Cell Immunol 2003, 221:15–26.
Eibl N, Spatz M, Fischer GF, et al.: Impaired primary immune response in type-1 diabetes: results from a controlled vaccination study. Clin Immunol 2002, 103(3 Pt 1):249–259.
Kukreja A, Cost G, Marker J, et al.: Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 2002, 109:131–140.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Polychronakos, C. Animal models of spontaneous autoimmune diabetes: Notes on their relevance to the human disease. Curr Diab Rep 4, 151–154 (2004). https://doi.org/10.1007/s11892-004-0071-z
Issue Date:
DOI: https://doi.org/10.1007/s11892-004-0071-z